Alternatives to Harbor

The widest menu on our roster — injections, sublingual lozenges, daily drops, four brand-name pens and the approved oral GLP-1 — with three compounding pharmacies named, a flat price at any dose, and cancellation terms among the most restrictive we have read.

• serves all 50 states, where Harbor lists Does not publish a service area
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

Now confirmed to publish real GLP-1 prices — compounded semaglutide from $199, tirzepatide from $349, plus brand options — right on its products page, no consult required, contrary to what an earlier check found.

• serves all 50 states, where Harbor lists Does not publish a service area
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

The lowest advertised flat rate we checked this pass — $79/mo semaglutide, $129/mo tirzepatide, plus an unusual oral gum option — but the price rides on a 'locked forever' promo that real Trustpilot reviews say hasn't always held, and you pay before the eligibility consult happens.

• $20/mo cheaper than Harbor
• serves all 50 states, where Harbor lists Does not publish a service area
• has an oral option if you would rather not inject

A clean, all-50-states compounded option with named pharmacies, no membership and the consult included — reasonable and transparent on price, though it's a newer platform with thin public detail beyond the $199 headline.

• serves all 50 states, where Harbor lists Does not publish a service area
• has an oral option if you would rather not inject
• scores 78/100 against Harbor's 57

⛔ FDA warning letter #728279 (June 2026), which names tryeden.com. The most oversight-forward compounded program here — visible clinician involvement and lab framing — at $196/mo semaglutide or $296/mo tirzepatide, flat and nationwide.

• serves all 50 states, where Harbor lists Does not publish a service area
• scores 89/100 against Harbor's 57

Both molecules have confirmed, tiered pricing, which appears only inside the signup flow — the public site carries no price at all — with a real gotcha: the 3-month plan costs more per month than month-to-month.

• serves all 50 states, where Harbor lists Does not publish a service area
• offers FDA-approved brand pens, not just compounded
• scores 71/100 against Harbor's 57

The price-first pick: some of the lowest flat, all-inclusive compounded pricing we track, nationwide — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.

• serves all 50 states, where Harbor lists Does not publish a service area
• scores 80/100 against Harbor's 57

Compounded semaglutide at $199 a month and tirzepatide at $299, the same price at every dose, and the daily tablet costs the same as the injection on both — all of it on an open pricing page you reach without a quiz. Brand-name prices are published too, which is rare: Wegovy $999, Ozempic $899, Mounjaro $999, cash. Two things to know before you enter a card. The badge at the top of every page says no subscription, and its own FAQ then asks whether you can cancel your subscription and tells you to call before your next billing date — so it does recur, whatever the badge says. And nothing anywhere on the site says how many weeks of medication one $199 charge actually buys. It ships to all 50 states, and it carries a June 2026 FDA warning letter for false or misleading claims, which it has since fixed.

• serves all 50 states, where Harbor lists Does not publish a service area
• offers FDA-approved brand pens, not just compounded
• has an oral option if you would rather not inject

Compounded semaglutide at $79 a month and tirzepatide at $119, month to month, with no dose-based increase and — checked in its own checkout data rather than taken on trust — a renewal price identical to the joining price. That last part is rarer than it should be. Two things the homepage will not tell you. The $49 and $99 it advertises are the twelve-month totals divided by twelve, not a monthly rate you can start on, and the countdown beside them is not a real deadline: it read August 15th and then August 20th within the same hour. The larger caveat is corporate. NextMeds is operated by Trinity HealthCare Supply, LLC, which also runs Lean Meds, altRx and Trinity Meds, and that operator holds an open FDA warning letter.

• $20/mo cheaper than Harbor
• serves all 50 states, where Harbor lists Does not publish a service area